Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Shenzhen Xpect Vision Closes $14 Million Round for New Imaging Tech

CMS Acquires China Rights to Seven Generic Drugs from India's Sun Pharma

Nanjing Frontier Biotech Plans $285 Million IPO on Shanghai STAR Exchange

Beijing Baicare Closes $9 Million Round for Clinical Diagnostic Devices

Qiyu Biotech of Shanghai Completes A Funding Round for Novel Biologics

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

 

China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020

Other Events

CHINA HEALTHCARE SUMMIT 2019

Shanghai, China

November 18-20, 2019